ABIOMED

$301.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$5.59 (+1.89%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ABIOMED and other stocks, options, and ETFs commission-free!

About ABMD

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. The listed name for ABMD is ABIOMED, Inc. Common Stock.

CEO

Michael R. Minogue

Employees

1,536

Headquarters

Danvers, Massachusetts

Founded

1981

Market Cap

14.18B

Price-Earnings Ratio

68.57

Dividend Yield

—

Average Volume

305.40K

High Today

$302.57

Low Today

$281.00

Open Price

$297.24

Volume

407.22K

52 Week High

$387.40

52 Week Low

$119.01

ABMD News

MarketWatchMar 5

Abiomed Inc. stock rises Friday, still underperforms market

Shares of Abiomed Inc. ABMD, +1.89% rallied 1.89% to $301.22 Friday, on what proved to be an all-around positive trading session for the stock market, with the

Analyst Ratings

44%

of 9 ratings

Buy

44%

Hold

44%

Sell

11%

ABMD Earnings

$0.00

$0.45

$0.90

$1.35

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Apr 29, Pre-Market